leisure time -WSS

leisure time

author：hotspot 2025-09-30 14:08:57 - browse：98326

prostate cancer cells — Prostate cancer cells seen under the microscope. NIH

Prostate cancer tends to be the tortoise of tumors, growing and spreading slowly. When cancerous cells escape the golf ball-sized prostate, they can lodge in various places throughout the body. New research shows that where these cells go can affect how long a man survives.

When prostate cancer spreads, or metastasizes, about three-quarters of the time it takes up residence in the bones. Less common locations are the lungs, liver, and lymph nodes.

An international team of researchers pooled information from nine clinical trials to estimate the average survival times for men with prostate cancer that had spread to four different tissues. Metastasis to the lymph nodes was linked to the longest survival; metastasis to the liver led to the shortest.

“This important study confirms that one size does not fit all when it comes to metastatic prostate cancer,” said Dr. Marc Garnick, a prostate cancer specialist at Beth Israel Deaconess Medical Center in Boston.

The new study, led by Susan Halabi, a professor of biostatistics at Duke University School of Medicine, suggests that prostate cancer that skips the bones and spreads to the liver and lungs may represent a different disease than prostate cancer that invades bones or lymph nodes. The results were published Monday in the Journal of Clinical Oncology.

Median survival for metastatic prostate cancer is affected by metastasis site. Mark Dubowski for Duke Health

“A better understanding of how metastatic prostate cancer behaves in different locations is letting us tailor diagnostic approaches and treatments that we hope will improve outcomes,” Garnick said.

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Methadone treatment changes are coming. Do they go far enough?

WSS

Methadone treatment changes are coming. Do they go far enough?

The Karikó problem: Lessons for funding basic research

Readout Newsletter: Bluebird, CVS, Contineum

Health AI adoption puts security, privacy startups on investors' radar

U.K. researchers warn about biases in medical devices, algorithms

SCOTUS questions limit to govt efforts to fight misinformation

focus

leisure time

Wikipedia

In age of alternative facts, a scholarly course on calling out crap

Future doctors should be trained to promote social change

Moonlake's readout produced a cash windfall. Risks remain

Positive childhood experiences can help future health

The high cost of giving birth even with insurance

Physicians and social media: If you see something, say something?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Methadone treatment changes are coming. Do they go far enough?

At least 13 dead in Texas as scorching temps continue

Creating egg and sperm cells from stem cells raises ethical issues

leisure time

Asbestos, a deadly carcinogen, banned by EPA

Medicare innovation center doesn’t save money, experts say

RSV injection headlines need to be accurate for good uptake

Setback for rare diseases as Taysha Gene Therapies pulls back

Setback for rare diseases as Taysha Gene Therapies pulls back

Study points to new risk in gene therapy death of Terry Horgan

hotspot

explore

focus

hotspot